Clinical Trial Update: rhBMP-2 Versus Autograft in Critical Size Tibial Defects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rhBMP-2 to autograft for critical size tibial defects was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fractures

Drugs mentioned

• Autograft
• rhBMP-2 (bone morphogenetic protein-2)

Snippet

Sponsor: St. Louis University | Conditions: Tibial Fractures | Phase 4 | Status: TERMINATED | Results posted: 2018-03-13